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Detailed clinical, neuroradiological, histological, biochemical, and genetic investigations were undertaken
in a child suffering from Leigh syndrome. The clinical symptoms started at age five months and led to a
severe progressive neurodegenerative disorder causing epilepsy, psychomotor retardation, and
tetraspasticity. Biochemical measurement of skeletal muscle showed a severe decrease in mitochondrial
complex II. Sequencing of SDHA revealed compound heterozygosity for a nonsense mutation in exon 4
(W119X) and a missense mutation in exon 3 (A83V), both absent in normal controls. In six additional
patients—five with Leigh or Leigh-like syndrome and one with neuropathy and ataxia associated with
isolated deficiency of complex II—mutations in SDHA were not detected, indicating genetic heterogeneity.
D
efects of the human succinate dehydrogenase (SDH)
are associated with a highly variable clinical presenta-
tion, ranging from early onset encephalomyopathies to
tumour susceptibility in adults.1 2 SDH is made up of four
subunits—two soluble proteins, the flavoprotein (Fp, SdhA)
and the Fe-S protein (SdhB) which are anchored to the inner
membrane by the subunits SdhC and SdhD.1 2 Pathogenic
mutations in the SDHA gene have so far rarely been
described.3–7
CASE REPORT
The nine year old girl was first child of non-consanguineous
German parents. Family history was negative. The patient
was born healthy at 38 weeks after normal pregnancy
(weight 2700 g, length 49 cm, head circumference 34 cm).
At five months of age developmental delay with axial
hypotonia and gaze fixation difficulties were noted. At eight
months of age (weight 7780 g (50th centile), length 65 cm
(3rd centile), head circumference: 41 cm (3rd centile)),
neurological examination showed generalised muscular
hypotonia with axial predominance. She could not fix her
gaze and bilateral horizontal nystagmus was noted. Deep
tendon reflexes were bilaterally increased, with Achilles
clonus and Babinski sign. Neither grasping nor eye contact
was possible. Focal and generalised seizures were noted
clinically. Heart and abdominal organs were normal.
Electroencephalography (EEG) showed slow, irregular basic
activity and focal epileptic signs with secondary general-
isation and hypsarrythmia. Routine laboratory indices were
normal except for mildly increased lactate (in serum 2.9 mmol/l
(normal 0.5–2.2); in CSF 2.7 mmol/l (normal,2)) and creatine
kinase (170 U/l (normal ,100)). EEG, electronystagmography,
and visual evoked potentials were normal.
At the age of three years (length 83 cm (,3rd centile),
weight 9550 g (,3rd centile), head circumference 45 cm
(,3rd centile)) the child was alert, but not communicating.
Horizontal nystagmus, tetraspasticity with brisk deep tendon
reflexes, Achilles clonus, and Babinski sign were encoun-
tered. EEG showed epileptic activity provoked by photo-
stimulation and myoclonic jerks. BNS (Blitz-Nick-Salaam)
cramps were noted.
Over recent years the child has shown an arrest of
psychomotor functions with recurrent seizures and further
development of severe contractures. At the current age of
nine years she is tetraparetic, unable to speak, has complete
visual loss, and has seizures without involvement of other
organs. A muscle biopsy was done at age of nine years
because of possible prenatal consequences.
METHODS
Morphology and biochemistry of skeletal muscle
Serial cross sections (8 mm) were obtained for histochemical
stains according to standard procedures. Activities of the
respiratory chain (RC) complexes I–IV were determined in
skeletal muscle of the patient as described.8
DNA analysis
DNA and RNA extraction was done according to standard
purification protocols (Qiagen, Hildesheim, Germany). Direct
sequencing of fibroblast cDNA as well as the promoter region
was carried out according to Parfait et al.4 We constructed
intronic primers for amplification of the nuclear gene (online
only material). Polymerase chain reaction (PCR) for sequencing
the nuclear genewas done by using the HotStar Taq kit (Qiagen,
Hildesheim, Germany) with 50˚ C annealing temperature.
Denaturing high performance liquid chromatography
Denaturing high performance liquid chromatography
(DHPLC) analysis was carried out with the PCR product of
Abbreviations: DHPLC, denaturing high performance liquid
chromatography; RC, respiratory chain; SDH, succinate dehydrogenase
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exon 3 of SDHA as described9 on an automated HPLC device
equipped with a DNA separation column (WAVETM DNA
Fragment Analysis System: Transgenomic, San Jose,
California, USA). All fragments were separated by an
universal gradient, starting at 40% and ending at 70% of
buffer B (Transgenomic), over a period of seven minutes at
temperatures of 56 ,˚ 58 ,˚ and 59 C˚.
Immunoblotting
Twenty five micrograms of protein from skeletal muscle
homogenates were loaded on 12% polyacrylamide gels. The
following antibodies were used according to the recommen-
dations of the supplier: mouse monoclonal anti-SDHA
antibody (anti-complex II Fp 70 kDa, Molecular Probes,
1:2000), anti-chicken actin (Developmental Studies
Hybridoma Bank, University of Iowa, 1:2000) and secondary
anti-mouse IgG coupled to HRP (Dako) 1:2000. Signals were
visualised with enhanced chemiluminescence (ECL plus;
Amersham Pharmacia Biotech) according to the manufac-
turer’s recommendations.
RESULTS
Magnetic resonance imaging
Brain magnetic resonance imaging (MRI) at age eight
months showed bilateral cortical atrophy with massive T2
weighted signal intensities in the basal ganglia involving the
thalamus, pallidum, substantia nigra, nucleus ruber, and
nucleus caudatus; however, the brain stem and the cerebel-
lum were normal.
At age three years, cortical atrophy and ventricular
enlargement had markedly progressed. The T2 weighted
signal hyperintensities in the putamen and nucleus caudatus
were still present; however, the bilateral thalamus lesions
had disappeared. Defect myelination was described predo-
minantly in the periventricular white matter. Cerebellum and
pons were normal.
Morphology and biochemistry of skeletal muscle
Muscle biopsy of the left tibialis anterior muscle showed
normal results on light and electron microscopy.
Histochemistry for SDH showed equal staining of all fibres.
Biochemical measurements of the respiratory chain enzymes
revealed a significantly decreased activity of complex II
(3.7 U/gNCP; normal range 16 to 42 U/gNCP, 23% residual
activity) but no abnormalities in the activities of other RC
enzymes (pyruvate dehydrogenase and citrate synthase).
DNA analysis
Direct sequencing of SDHA revealed two compound hetero-
zygous mutations in the patient: one nonsense mutation in
exon 4 (W119X) inherited from the father, and a missense
mutation in exon 3 (A83V) inherited from the mother. Both
mutations were also present in the patient’s cDNA; however,
the W119X allele was difficult to detect, possibly because of
nonsense mediated decay. A83V was not present in 100
normal control DNA samples screened by WAVE. Sequencing
of all exons, the exon–intron boundaries, and the SDHA
promoter region revealed several polymorphisms, present in
the patient as well as in control DNA samples (online-only
material).
By sequencing the cDNA of SDHA, we detected an
additional cDNA species expressed by the previously
described SDHA pseudogene on chromosome 3 that showed
a few differences compared with the ‘‘true’’ SDHA gene on
chromosome 5, including a frameshift mutation leading to a
stop codon in exon 2.
Immunoblotting
Immunoblotting with anti-SDHA antibody (CII Fp) showed a
significantly diminished signal in the patient compared with
controls, thus indicating a reduced steady state level of this
protein. As a control for the equal loading, an immunodetec-
tion of the same blot was performed using actin antibody
(fig 1).
DISCUSSION
Isolated complex II deficiency is a very rare condition,
occurring in approximately 2–4% of all respiratory chain
enzyme deficiencies.4 Mutations of SDHA have been reported
in only five families so far. Three of these presented with
autosomal recessive Leigh syndrome,3–5 and one child died
suddenly at the age of five months from a severe deteriora-
tion of neuromuscular, cardiac, and hepatic symptoms after
an intermittent infection.6 All of these children were carrying
missense mutations in the C-terminal domain. In the fifth
family, two siblings suffered from late onset optic atrophy,
ataxia, and myopathy, and a heterozygous mutation was
identified, suggesting a possible role of SDHA mutations in
autosomal dominant neurodegenerative disorders.7 Further
studies showed that several patients with complex II
deficiency do not have mutations of SDHA. This suggested a
role of additional nuclear genes involved in synthesis,
assembly, or maintenance of SDH.4 Interestingly, dominant
mutations of the three other SDH subunit genes (SDHB,
SDHC, and SDHD) were only described in association with
tumours, such as hereditary paraganglioma and abdominal
phaeochromocytoma.10
The biochemical complex II defect in our patient was
confirmed by a significantly reduced level of SDHA protein in
muscle and compound heterozygote mutations in the SDHA
gene. Although the activity of complex II was markedly
reduced (23% rest activity), SDH was still detectable by
histochemistry. We hypothesise that partial SDH decrease
may be overlooked if histochemistry only is performed. The
heterozygote missense mutation (A83V) inherited from the
mother occurred in a region of the protein which is conserved
over a wide range of species (online-only material). It was
not found in more than 200 control alleles. W119X is the first
stop mutation described in SDHA; all other previously
described mutations were missense mutations. Both parents
are healthy and carry one of the mutations heterozygously,
supporting a recessive trait in this family.
Parfait et al4 reported two almost identical SDHA gene
copies encoding SDHA (Chr 5p15 and 3q29) with preserved
genomic organisation (15 exons for both copies). The SDHA
copy on chromosome 3q29 contains a 1 base pair (bp)
1 2 3 4 5
CII Fp
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45 kDa
Figure 1 Upper panel: Immunoblotting with anti-SDHA antibody (CII
Fp) showed a significantly diminished signal in the muscle homogenate
from the patient (lane 2) compared with normal controls (lanes 1, 3, 4,
and 5), thus indicating a reduced steady state level of SDHA. Lower
panel: Incubation of the same blot with anti-actin antibody revealed
equal loading.
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deletion in exon 2 which is predicted to cause a frameshift
and premature termination of the amino acid chain. Thus the
SDHA copy on Chr 3q29 probably represents a pseudogene.
However, by analysing cDNA as described4 we found that
both SDHA copies are expressed, which is in contrast to a
previous report.3 Thus by screening cDNA only, heterozygous
mutations might easily be missed as they represent 25% (one
in four alleles) or fewer. This may cast doubt on an SDHA
mutation detected by cDNA sequencing which was thought
to have a ‘‘dominant’’ effect.7 11 We therefore designed
intronic primers to specifically amplify and sequence the
SDHA gene on chromosome 5.
Six additional patients of our cohort similarly showed a
severe isolated complex II deficiency—five presented with
Leigh or Leigh-like syndrome and one with neuropathy and
ataxia (table 1).
No pathogenic mutations in SDHA were found, suggesting
genetic heterogeneity that confirms previous studies.4
Further investigation using cells or tissues of these patients
are warranted in order to identify additional genes and thus
far unknown mechanisms involved in the maintenance and
assembly of mitochondrial complex II.
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Table 1 Clinical summary of six patients with isolated complex II deficiency not showing
SDHA mutations
Patient Age of onset Family history Clinical symptoms
Complex II activity
(% lower normal range)
AJ (female) Early infancy Sporadic Severe muscular hypotonia 50%
LS (female) 5 m Sporadic Muscular hypotonia,
psychomotor retardation
60%
MC (female) 1 y Sporadic Typical Leigh syndrome,
hypertrophic cardiomyopathy
25%
MR (male) Early infancy Sporadic Severe muscular hypotonia,
psychomotor retardation
30%
TS (male) 3 m Affected sibling,
consanguineous
parents
Muscular hypotonia,
respiratory insufficiency,
psychomotor retardation,
epilepsy
40%
BR (male) 3 y Sporadic Ataxia, neuropathy 60%
m, months; y, years.
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